Article
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
2021-04-16
Abstract excerpt
SARS-CoV-2 infection in immunocompromised individuals is associated with prolonged virus shedding and evolution of viral variants. Rapamycin and its analogs (rapalogs, including everolimus, temsirolimus, and ridaforolimus) are FDA-approved as mTOR inhibitors for the treatment of human diseases, including cancer and autoimmunity. Rapalog use is commonly associated with increased susceptibility to infection, which h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40423237-dfa5-5868-81f5-389d6aab3c58
- DOI
- 10.1101/2021.04.15.440067
